期刊
ONCOTARGET
卷 6, 期 29, 页码 27891-27906出版社
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.4451
关键词
ABIN-2; deubiquitylase; miR let-7a; NF-kappa B; USP35
资金
- National Natural Science Foundation of China [81172045, 81470127]
- Shandong Provincial Natural Science Foundation [ZR2014HM032]
Ubiquitin specific protease 35 (USP35) is a member of deubiquitylases (DUBs). It remains largely unknown about the biological role and the regulation mechanism of USP35. Here, we first identified miR let-7a as a positive regulator of USP35 expression and showed that USP35 expression positively correlates with miR let-7a expression in different cancer cell lines and tissues. Then, we showed that USP35 expression was decreased dramatically in the tumor tissues compared with the adjacent non-cancerous tissues. USP35 overexpression inhibited cell proliferation in vitro and inhibited xenograft tumor growth in vivo. Furthermore, we revealed that USP35 acts as a functional DUB and stabilizes TNFAIP3 interacting protein 2 (ABIN-2) by promoting its deubiquitination. Functionally, both ABIN-2 and USP35 could inhibit TNF alpha-induced NF kappa B activation and overexpression of ABIN-2 alleviated USP35-loss induced activation of NF-kappa B. Collectively, our data indicated that miR let-7a-regulated USP35 can inhibit NF-kappa B activation by deubiquitination and stabilization of ABIN-2 protein and eventually inhibit cell proliferation. Overall, our study provides a novel rationale of targeting miR let-7a-USP35-ABIN-2 pathway for the therapy of cancer patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据